Loading clinical trials...
Loading clinical trials...
This is an open-label extension study of a single intratympanic injection of OTO-104 given every 3 months for a total of 2 injections. Subjects must have completed either Otonomy study 104-201403 (1-Y...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otonomy, Inc.
NCT06859788 · Meniere's Disease, Ménière's Disease
NCT06278129 · Sudden Sensorineural Hearing Loss, Meniere Disease, and more
NCT04026516 · Meniere's Disease, Benign Paroxysmal Positional Vertigo, and more
NCT02612337 · Meniere's Disease
NCT01526408 · Meniere's Disease
Many sites in Europe. Refer to the contact info listed below.
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions